{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:41:59Z","timestamp":1768311719921,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,9]]},"DOI":"10.7759\/cureus.20288","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T08:25:58Z","timestamp":1639038358000},"source":"Crossref","is-referenced-by-count":2,"title":["Serum Ghrelin Concentration in Patients With Primary Biliary Cirrhosis (PBC)"],"prefix":"10.7759","author":[{"given":"Rania","family":"Naguib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amel","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Elkemary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23421","article-title":"Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans","volume":"51","author":"Moreno M","year":"2010","unstructured":"Moreno M, Chaves JF, Sancho-Bru P, et al.. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology. 2010, 51:974-85. 10.1002\/hep.23421","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2015.03.005","article-title":"Ghrelin","volume":"4","author":"M\u00fcller TD","year":"2015","unstructured":"M\u00fcller TD, Nogueiras R, Andermann ML, et al.. Ghrelin. Mol Metab. 2015, 4:437-60. 10.1016\/j.molmet.2015.03.005","journal-title":"Mol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2016.12.003","article-title":"Current understanding of the hypothalamic ghrelin pathways inducing appetite and adiposity","volume":"40","author":"Al Massadi O","year":"2017","unstructured":"Al Massadi O, L\u00f3pez M, Tsch\u00f6p M, Di\u00e9guez C, Nogueiras R. Current understanding of the hypothalamic ghrelin pathways inducing appetite and adiposity. Trends Neurosci. 2017, 40:167-80. 10.1016\/j.tins.2016.12.003","journal-title":"Trends Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4432","article-title":"Asprosin is a centrally acting orexigenic hormone","volume":"23","author":"Duerrschmid C","year":"2017","unstructured":"Duerrschmid C, He Y, Wang C, et al.. Asprosin is a centrally acting orexigenic hormone. Nat Med. 2017, 23:1444-53. 10.1038\/nm.4432","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i11.3214","article-title":"Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease","volume":"21","author":"Zhang SR","year":"2015","unstructured":"Zhang SR, Fan XM. Ghrelin-ghrelin O-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2015, 21:3214-22. 10.3748\/wjg.v21.i11.3214","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32835609b0","article-title":"How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease","volume":"24","author":"Machado MV","year":"2012","unstructured":"Machado MV, Coutinho J, Carepa F, Costa A, Proen\u00e7a H, Cortez-Pinto H. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2012, 24:1166-72. 10.1097\/MEG.0b013e32835609b0","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-019-09528-6","article-title":"Ghrelin and liver disease","volume":"21","author":"Qui\u00f1ones M","year":"2020","unstructured":"Qui\u00f1ones M, Fern\u00f8 J, Al-Massadi O. Ghrelin and liver disease. Rev Endocr Metab Disord. 2020, 21:45-56. 10.1007\/s11154-019-09528-6","journal-title":"Rev Endocr Metab Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2018.05.006","article-title":"Ghrelin and the heart","volume":"111","author":"Tokudome T","year":"2019","unstructured":"Tokudome T, Otani K, Miyazato M, Kangawa K. Ghrelin and the heart. Peptides. 2019, 111:42-6. 10.1016\/j.peptides.2018.05.006","journal-title":"Peptides"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002271107","article-title":"Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice","volume":"107","author":"Zhao TJ","year":"2010","unstructured":"Zhao TJ, Liang G, Li RL, et al.. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci U S A. 2010, 107:7467-72. 10.1073\/pnas.1002271107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12688","article-title":"Ghrelin deletion protects against age-associated hepatic steatosis by downregulating the C\/EBP\u03b1-p300\/DGAT1 pathway","volume":"17","author":"Guillory B","year":"2018","unstructured":"Guillory B, Jawanmardi N, Iakova P, Anderson B, Zang P, Timchenko NA, Garcia JM. Ghrelin deletion protects against age-associated hepatic steatosis by downregulating the C\/EBP\u03b1-p300\/DGAT1 pathway. Aging Cell. 2018, 17:10.1111\/acel.12688","journal-title":"Aging Cell"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2009.01.005","article-title":"Aging and liver regeneration","volume":"20","author":"Timchenko NA","year":"2009","unstructured":"Timchenko NA. Aging and liver regeneration. Trends Endocrinol Metab. 2009, 20:171-6. 10.1016\/j.tem.2009.01.005","journal-title":"Trends Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220795","article-title":"Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus","volume":"144","author":"Seoane LM","year":"2003","unstructured":"Seoane LM, L\u00f3pez M, Tovar S, Casanueva FF, Se\u00f1ar\u00eds R, Di\u00e9guez C. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology. 2003, 144:544-51. 10.1210\/en.2002-220795","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0305930101","article-title":"Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor","volume":"101","author":"Sun Y","year":"2004","unstructured":"Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A. 2004, 101:4679-84. 10.1073\/pnas.0305930101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/1871527315666160709203525","article-title":"Functions of ghrelin in brain, gut and liver","volume":"15","author":"Stasi C","year":"2016","unstructured":"Stasi C, Milani S. Functions of ghrelin in brain, gut and liver. CNS Neurol Disord Drug Targets. 2016, 15:956-63. 10.2174\/1871527315666160709203525","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2012.10.004","article-title":"Ghrelin, leptin and insulin in cirrhotic children and adolescents: relationship with cirrhosis severity and nutritional status","volume":"180","author":"Dornelles CT","year":"2013","unstructured":"Dornelles CT, Goldani HA, Wilasco MI, et al.. Ghrelin, leptin and insulin in cirrhotic children and adolescents: relationship with cirrhosis severity and nutritional status. Regul Pept. 2013, 180:26-32. 10.1016\/j.regpep.2012.10.004","journal-title":"Regul Pept"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/00365511003763349","article-title":"Total and acylated ghrelin in liver cirrhosis: correlation with clinical and nutritional status","volume":"70","author":"El-Shehaby AM","year":"2010","unstructured":"El-Shehaby AM, Obaia EM, Alwakil SS, Hiekal AA. Total and acylated ghrelin in liver cirrhosis: correlation with clinical and nutritional status. Scand J Clin Lab Invest. 2010, 70:252-8. 10.3109\/00365511003763349","journal-title":"Scand J Clin Lab Invest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2011.07.002","article-title":"Study of serum ghrelin changes and its correlation with malnutrition in liver cirrhosis in Egypt","volume":"35","author":"Elbadri A","year":"2011","unstructured":"Elbadri A, Esmat S, Abosaif N, Morsi A, Shaker O. Study of serum ghrelin changes and its correlation with malnutrition in liver cirrhosis in Egypt. Clin Res Hepatol Gastroenterol. 2011, 35:638-43. 10.1016\/j.clinre.2011.07.002","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102328","article-title":"The challenges of primary biliary cholangitis: what is new and what needs to be done","author":"Terziroli Beretta-Piccoli B","year":"2019","unstructured":"Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, et al.. The challenges of primary biliary cholangitis: what is new and what needs to be done. J Autoimmun. 2019, 105:102328. Accessed: Jun 27]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31548157\/. 10.1016\/j.jaut.2019.102328"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.18.05774-9","article-title":"Management of primary biliary cholangitis prior to obeticholic acid availability","volume":"109","author":"Durazzo M","year":"2018","unstructured":"Durazzo M, Bonetto S, Fagoonee S, Morgando A, Pellicano R. Management of primary biliary cholangitis prior to obeticholic acid availability. Minerva Med. 2018, 109:410-7. 10.23736\/S0026-4806.18.05774-9","journal-title":"Minerva Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2017.12.021","article-title":"Primary biliary cholangitis","volume":"151","author":"Par\u00e9s A","year":"2018","unstructured":"Par\u00e9s A. Primary biliary cholangitis. Med Clin (Barc). 2018, 151:242-9. 10.1016\/j.medcli.2017.12.021","journal-title":"Med Clin (Barc)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens F","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G, et al.. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016, 375:631-43. 10.1056\/NEJMoa1509840","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2018.03.003","article-title":"Current treatment options for primary biliary cholangitis","volume":"22","author":"Wong KA","year":"2018","unstructured":"Wong KA, Bahar R, Liu CH, Bowlus CL. Current treatment options for primary biliary cholangitis. Clin Liver Dis. 2018, 22:481-500. 10.1016\/j.cld.2018.03.003","journal-title":"Clin Liver Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i25.7683","article-title":"Primary biliary cirrhosis: clinical and laboratory criteria for its diagnosis","volume":"21","author":"Reshetnyak VI","year":"2015","unstructured":"Reshetnyak VI. Primary biliary cirrhosis: clinical and laboratory criteria for its diagnosis. World J Gastroenterol. 2015, 21:7683-708. 10.3748\/wjg.v21.i25.7683","journal-title":"World J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1621-5","article-title":"The interaction between apolipoprotein B insertion\/deletion polymorphism and macronutrient intake on lipid profile and serum leptin and ghrelin levels in type 2 diabetes mellitus patients","volume":"58","author":"Rafiee M","year":"2019","unstructured":"Rafiee M, Sotoudeh G, Djalali M, et al.. The interaction between apolipoprotein B insertion\/deletion polymorphism and macronutrient intake on lipid profile and serum leptin and ghrelin levels in type 2 diabetes mellitus patients. Eur J Nutr. 2019, 58:1055-65. 10.1007\/s00394-018-1621-5","journal-title":"Eur J Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0508","article-title":"Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation","volume":"163","author":"Diz-Lois MT","year":"2010","unstructured":"Diz-Lois MT, Garcia-Buela J, Suarez F, Sangiao-Alvarellos S, Vidal O, Cordido F. Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation. Eur J Endocrinol. 2010, 163:609-16. 10.1530\/EJE-10-0508","journal-title":"Eur J Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031771","article-title":"Plasma ghrelin concentrations, food intake, and anorexia in liver failure","volume":"89","author":"Marchesini G","year":"2004","unstructured":"Marchesini G, Bianchi G, Lucidi P, Villanova N, Zoli M, De Feo P. Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J Clin Endocrinol Metab. 2004, 89:2136-41. 10.1210\/jc.2003-031771","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(02)00438-5","article-title":"Ghrelin in chronic liver disease","volume":"38","author":"Tacke F","year":"2003","unstructured":"Tacke F, Brabant G, Kruck E, et al.. Ghrelin in chronic liver disease. J Hepatol. 2003, 38:447-54. 10.1016\/s0168-8278(02)00438-5","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2007.08.014","article-title":"Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats","volume":"146","author":"I\u015feri SO","year":"2008","unstructured":"I\u015feri SO, Sener G, Saglam B, Ercan F, Gedik N, Ye\u011fen BC. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul Pept. 2008, 146:73-9. 10.1016\/j.regpep.2007.08.014","journal-title":"Regul Pept"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-011-0475-1","article-title":"Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease","volume":"21","author":"Estep M","year":"2011","unstructured":"Estep M, Abawi M, Jarrar M, et al.. Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease. Obes Surg. 2011, 21:1750-7. 10.1007\/s11695-011-0475-1","journal-title":"Obes Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-009-9170-6","article-title":"Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation","volume":"35","author":"Diz-Lois MT","year":"2009","unstructured":"Diz-Lois MT, Garcia-Buela J, Suarez F, Sangiao-Alvarellos S, Vidal O, Cordido F. Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation. Endocrine. 2009, 35:467-76. 10.1007\/s12020-009-9170-6","journal-title":"Endocrine"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-817819","article-title":"Ghrelin\/leptin-imbalance in patients with primary biliary cirrhosis","volume":"112","author":"Breidert M","year":"2004","unstructured":"Breidert M, Zimmermann TF, Schneider R, Ehninger G, Brabant G. Ghrelin\/leptin-imbalance in patients with primary biliary cirrhosis. Exp Clin Endocrinol Diabetes. 2004, 112:123-6. 10.1055\/s-2004-817819","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02011.x","article-title":"The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state","volume":"60","author":"Broglio F","year":"2004","unstructured":"Broglio F, Gianotti L, Destefanis S, et al.. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf). 2004, 60:592-9. 10.1111\/j.1365-2265.2004.02011.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnr.0000078703.79393.d2","article-title":"Changes in ghrelin and ghrelin receptor expression according to feeding status","volume":"14","author":"Kim MS","year":"2003","unstructured":"Kim MS, Yoon CY, Park KH, et al.. Changes in ghrelin and ghrelin receptor expression according to feeding status. Neuroreport. 2003, 14:1317-20. 10.1097\/01.wnr.0000078703.79393.d2","journal-title":"Neuroreport"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0174","article-title":"Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration","volume":"146","author":"Sato T","year":"2005","unstructured":"Sato T, Fukue Y, Teranishi H, Yoshida Y, Kojima M. Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-d-glucose administration. Endocrinology. 2005, 146:2510-6. 10.1210\/en.2005-0174","journal-title":"Endocrinology"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1155\/MI\/2006\/78380","article-title":"The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection","volume":"2006","author":"Ataseven H","year":"2006","unstructured":"Ataseven H, Bahcecioglu IH, Kuzu N, Yalniz M, Celebi S, Erensoy A, Ustundag B. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm. 2006, 2006:78380. 10.1155\/MI\/2006\/78380","journal-title":"Mediators Inflamm"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.3.808","article-title":"Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure","volume":"85","author":"Kalaitzakis E","year":"2007","unstructured":"Kalaitzakis E, Bosaeus I, Ohman L, Bj\u00f6rnsson E. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr. 2007, 85:808-15. 10.1093\/ajcn\/85.3.808","journal-title":"Am J Clin Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78914-serum-ghrelin-concentration-in-patients-with-primary-biliary-cirrhosis-pbc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:16Z","timestamp":1707507196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78914-serum-ghrelin-concentration-in-patients-with-primary-biliary-cirrhosis-pbc"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.20288","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,9]]}}}